Press Release: Adamas : Looming Deadline - Levi & Korsinsky Encourages Shareholders of Adamas ...

(PR-inside.com) NEW YORK, NY / ACCESSWIRE / June 4, 2024 / Levi & Korsinsky informs shareholders that a settlement has been reached in the pending class action lawsuit against Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS). The settlement provides for a fund of $4,650,000 to benefit class members. For the purposes of the settlement, the class is defined as: all persons and entities that purchased or otherwise acquired the publicly traded common stock of Adamas, between August 8, 2017 and March 4, 2019, both dates inclusive (the "Settlement Class Period"), and were damaged thereby. If you are a class member as defined above, you may ..